Remdesivir for the Treatment of Covid-19 -- Final Report.

• Authors : Beigel, J. H.¹ ; Tomashek, K. M.¹; Dodd, L. E.¹

Subjects: *COVID-19 treatment; *REMDESIVIR; *COVID-19NATIONAL Institute of Allergy & Infectious Diseases (U.S.)

• Source: New England Journal of Medicine. 11/5/2020, Vol. 383 Issue 19, p1813-1826. 14p.

• Abstract: BACKGROUND Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral ... Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.

• Authors : Geleris, Joshua^1,2; Sun, Yifei³; Platt, Jonathan⁴

Subjects: *HYDROXYCHLOROQUINE; *COVID-19; *HOSPITAL patients

• Source: New England Journal of Medicine. 7/18/2020, Vol. 382 Issue 25, p2411-2418. 8p.

• Abstract: BACKGROUND Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. METHODS We examined the association ... Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

The Untold Toll — The Pandemic’s Effects on Patients without Covid-19.

• Authors : Rosenbaum, Lisa

Subjects: *COVID-19; *PANDEMICS; *COVID-19 pandemic

• Source: New England Journal of Medicine. 6/11/2020, Vol. 382 Issue 24, p2368-2371. 4p.

• Abstract: The article offers information about the Covid-19 pandemic's effects on patients without Covid-19. It discusses the

Record details

Compassionate Use of Remdesivir for Patients with Severe Covid-19.

• Authors : Grein, Jonathan¹; Norio Ohmagari²; Shin, Daniel³

Subjects: *COVID-19; *REMDESIVIR; *RNA polymerases

• Source: New England Journal of Medicine. 6/11/2020, Vol. 382 Issue 24, p2327-2336. 10p.

• Abstract: BACKGROUND Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2. METHODS We provided ... Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

History in a Crisis — Lessons for Covid-19.

• Authors : Jones, David S.¹

Subjects: *COVID-19; *MEDICAL personnel; *EMERGING infectious diseases

• Source: New England Journal of Medicine. 4/30/2020, Vol. 382 Issue 18, p1681-1683. 3p.

• Abstract: In this article the author talks about crisis in previous centuries and offered several lesson for Covid-19. topics discussed herpes and ...

Record details

Defining the Epidemiology of Covid-19 - Studies Needed.

• Authors : Lipsitch, Marc¹; Swerdlow, David L.²; Finelli, Lyn³

Subjects: *PREVENTION of epidemics; *PREVENTION of infectious disease transmission; *AGE distributionCHINA

• Source: New England Journal of Medicine. 3/26/2020, Vol. 382 Issue 13, p1194-1196. 3p.

• Abstract: The article offers information on the epidemiology of Covid-19. Topics discussed include the impact of an epidemic depends on the number ...

Record details

Remdesivir for the Treatment of Covid-19 — Preliminary Report.

• Authors : Olalla, Julian¹

Subjects: *COVID-19; *REMDESIVIR; *HERPES genitalis

• Source: New England Journal of Medicine. 9/3/2020, Vol. 383 Issue 10, p993-994. 2p.

Record details

Remdesivir for the Treatment of Covid-19 — Preliminary Report.

• Authors : McMahon, James H.¹ ; Udy, Andrew¹; Peleg, Anton Y.¹

Subjects: *REMDESIVIR; *COVID-19; *COMMUNITY-acquired pneumonia

• Source: New England Journal of Medicine. 9/3/2020, Vol. 383 Issue 10, p992-993. 2p.

Record details

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

• Authors : Goldman, Jason D.¹; Lye, David C. B.²; Hui, David S.³

Subjects: *COVID-19; *REMDESIVIR; *ARTIFICIAL respirationGILEAD Sciences Inc. 185049848 GILEAD Sciences Inc. GILEAD Sciences Inc. 185049848 185049848 GILEAD Sciences Inc. 185049848 GILD

• Source: New England Journal of Medicine. 11/5/2020, Vol. 383 Issue 19, p1827-1837. 11p.

• Abstract: Background: Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of coronavirusCopyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

• Authors : Okafor, Elizabeth C.¹; Pastick, Katelyn A.¹; Rajasingham, Radha¹

Subjects: *COVID-19; *HYDROXYCHLOROQUINE; *PREVENTIVE medicine

• Source: New England Journal of Medicine. 9/10/2020, Vol. 383 Issue 11, p1089-1089. 3/4p.

• Abstract: The article presents the reply of the article Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 using a pragmatic trial design and trial ...

Record details